Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria T Staevska

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Therapeutics and Clinical Risk Management|December 10, 2016
Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticariaMaria T Staevska
Clinical Allergy and Immunology|December 13, 2006
Rhinitis and sleep apneaMaria T Staevska, James N Baraniuk
Clinical Allergy and Immunology|December 13, 2006
Differential diagnosis of persistent nonallergic rhinitis and rhinosinusitis syndromesMaria T Staevska, James N Baraniuk
Current Allergy and Asthma Reports|April 2, 2004
Rhinitis and sleep apneaMaria T Staevska, Mariana A Mandajieva, Vasil D Dimitrov
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 4, 2012
Characteristics of a patient population seeking medical advice for nasal symptoms in BulgariaTodor A Popov, Tanya Z Kralimarkova, Maria T Staevska, et al.
The World Allergy Organization Journal|April 20, 2016
Clinical characteristics of patients seeking medical advice for nasal symptoms in Bulgaria with special focus on childrenTihomir B Mustakov, Todor A Popov, Tanya Z Kralimarkova, et al.
American Journal of Rhinology & Allergy|April 14, 2018
A Three-Year Course of House Dust Mite Sublingual Immunotherapy Appears Effective in Controlling the Symptoms of Allergic RhinitisSilviya M Novakova, Plamena I Novakova, Plamen H Yakovliev, et al.
The World Allergy Organization Journal|May 17, 2021
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registryAnna Valerieva, Maria T Staevska, Vesna Grivcheva-Panovska, et al.
The Lancet. Haematology|March 22, 2026
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trialMarcus Maurer, Marcin Stobiecki, Anna Valerieva, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Therapeutics and Clinical Risk Management|December 10, 2016
Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticariaMaria T Staevska
Clinical Allergy and Immunology|December 13, 2006
Rhinitis and sleep apneaMaria T Staevska, James N Baraniuk
Clinical Allergy and Immunology|December 13, 2006
Differential diagnosis of persistent nonallergic rhinitis and rhinosinusitis syndromesMaria T Staevska, James N Baraniuk
Current Allergy and Asthma Reports|April 2, 2004
Rhinitis and sleep apneaMaria T Staevska, Mariana A Mandajieva, Vasil D Dimitrov
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 4, 2012
Characteristics of a patient population seeking medical advice for nasal symptoms in BulgariaTodor A Popov, Tanya Z Kralimarkova, Maria T Staevska, et al.
The World Allergy Organization Journal|April 20, 2016
Clinical characteristics of patients seeking medical advice for nasal symptoms in Bulgaria with special focus on childrenTihomir B Mustakov, Todor A Popov, Tanya Z Kralimarkova, et al.
American Journal of Rhinology & Allergy|April 14, 2018
A Three-Year Course of House Dust Mite Sublingual Immunotherapy Appears Effective in Controlling the Symptoms of Allergic RhinitisSilviya M Novakova, Plamena I Novakova, Plamen H Yakovliev, et al.
The World Allergy Organization Journal|May 17, 2021
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registryAnna Valerieva, Maria T Staevska, Vesna Grivcheva-Panovska, et al.
The Lancet. Haematology|March 22, 2026
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trialMarcus Maurer, Marcin Stobiecki, Anna Valerieva, et al.
Pageof 1